FDA product code CIN: Electrophoretic Separation, Alkaline Phosphatase Isoenzymes
CIN is the FDA product code for electrophoretic separation, alkaline phosphatase isoenzymes. It is a Class II device, regulated under 21 CFR 862.1050 and reviewed by the Clinical Chemistry panel. FDA has cleared 26 510(k) submissions under CIN, 1 in the last five years, from 18 different applicants. The average 510(k) review took 95 days (median 60); 210 days on average over the last three years. FDA has posted 7 recalls for CIN devices.
Classification
| Field | Value |
|---|---|
| Device name | Electrophoretic Separation, Alkaline Phosphatase Isoenzymes |
| Device class | Class II |
| Regulation | 21 CFR 862.1050 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for CIN
| Year | Clearances | Avg. review days |
|---|---|---|
| 2020 | 1 | 217 |
| 2024 | 1 | 210 |
Compare with all 510(k) review times · Search every CIN clearance
Top CIN applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Helena Laboratories | 5 | 2002-05-06 |
| Hybritech, Inc. | 3 | 1997-09-11 |
| Metra Biosystems, Inc. | 2 | 1998-05-27 |
| Sigma Chemical Co. | 2 | 1977-08-03 |
| Beckman Coulter | 1 | 2024-04-15 |
13 more applicants have CIN clearances. See the full list in Caduvo.
Most recent CIN clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K232904 | Beckman Coulter | Access Ostase | 2024-04-15 | 210 |
| K200475 | Immunodiagnostic Systems , Ltd. | IDS-iSYS Ostase BAP | 2020-09-30 | 217 |
| K043125 | Orion Diagnostica, OY | ORION DIAGNOSTICA UNIQ PINP RIA | 2005-05-04 | 173 |
| K020625 | Helena Laboratories | SPIFE 2000/3000 ALP 40, 20; MODELS 3345 AND 3346 | 2002-05-06 | 69 |
| K011113 | Sebia | HYDRAGEL ISO-PAL K20 (PN 3022); HYDRAGEL 7 ISO-PAL (PN 4112); HYDRAGEL 15 ISO-PAL (PN 4132) | 2001-06-13 | 63 |
Recalls for CIN devices
7 product recalls in 4 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2016-07-14.
Frequently asked questions
What is FDA product code CIN?
CIN is the FDA product code for electrophoretic separation, alkaline phosphatase isoenzymes. It is a Class II device, regulated under 21 CFR 862.1050 and reviewed by the Clinical Chemistry panel.
What device class is CIN?
Class II, regulation 21 CFR 862.1050. Typical premarket route: 510(k).
How long does a 510(k) take for product code CIN?
Across 26 cleared submissions the average was 95 days from receipt to decision (median 60).
Which companies have the most CIN clearances?
Helena Laboratories (5); Hybritech, Inc. (3); Metra Biosystems, Inc. (2); Sigma Chemical Co. (2); Beckman Coulter (1).
Have CIN devices been recalled?
Yes: 7 product recalls across 4 recall events; the most recent began 2016-07-14.
Next steps
- Run an FDA pathway report with predicate devices for product code CIN
- Run a recall and safety report across every CIN manufacturer
- Watch product code CIN for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times